JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer

NCT07336771 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer
Locally Advanced Breast Cancer (LABC)

Interventions

DRUG: JSKN016 Q2W
DRUG: JSKN016 Q3W
DRUG: D-0502

Sponsor

Jiangsu Alphamab Biopharmaceuticals Co., Ltd